Aspen Abacavir 300mg FC Tablets
PDF Leaflet Revision Date: 02 June 2017
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 in infected adults.
Dosage (summary)
1 tablet (300 mg) twice daily or 2 tablets (600 mg) once daily.
Onset of Action / Duration
Onset: 11 days, Duration: Not specified.
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Ethanol increases AUC
- Ribavirin caution advised
Contraindications
- Hypersensitivity to abacavir
- Moderate or severe hepatic impairment
- Pregnancy
- Lactation
Common side effects
- Hypersensitivity reactions
- Nausea
- Diarrhoea
- Rash
- Fatigue
Counselling Points
- Monitor for hypersensitivity symptoms
- Do not restart after hypersensitivity
- Avoid alcohol
Serious warnings
- Serious hypersensitivity reactions
- Lactic acidosis risk
- Hepatotoxicity
Important Disclaimer
The Aspen Abacavir 300mg FC Tablets professional information leaflet below is the property of Pharmacare Limited and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
